Last update Jan. 28, 2022
Very Low Risk
Antibacterial used alone or in combination with sulfonamides. Oral administration in two daily doses.
It is excreted in breast milk in clinically non-significant amount. (Borderon 1975, Miller 1974 y 1973, Arnauld 1972)
No problems have been observed in infants whose mothers were treated. (Ito 1993)
Medication which is used in infants from the second month of age.
Although rare, the possibility of transient gastroenteritis due to alteration of the intestinal flora in infants whose mothers take antibacterial should be taken into account.(Ito 1993)
Expert authors consider the use of this madication to be compatible during breastfeeding. (Hale, Briggs 2015, Schaefer2015, Mitrano 2009, Kaiser 2007, Chin 2001)
The American Academy of Pediatric states that it is usually compatible with breastfeeding medication. (AAP 2001)
WHO List of Essential Medicines from 2002 has classified it as compatible with breastfeeding. (OMS-UNICEF 2002)
We do not have alternatives for C14H18N4O3 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM